Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
06/1993
06/01/1993US5215888 Kit for assaying the cellular integrity of blood platelets
05/1993
05/27/1993WO1993010461A1 Non-radioactive enzyme assay
05/27/1993WO1993010148A1 Muramyl compounds for treatment of septic shock
05/27/1993WO1993009668A1 Combinatorial strategies for polymer synthesis
05/27/1993WO1993006130A1 Neurotensin method for inhibiting vascular leakage
05/27/1993WO1993003058A3 Non-desensitizing analogs of gnrh and other biologically active ligands
05/27/1993CA2121842A1 Non-radioactive enzyme assay
05/27/1993CA2118805A1 Neurotensin method for inhibiting vascular leakage
05/26/1993EP0542937A1 Growth hormone releasing factor analogs
05/26/1993EP0542899A1 Peptides of the chromostatin family
05/26/1993EP0542770A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
05/26/1993EP0397679B1 New anti-inflammatory agents
05/26/1993EP0167575B1 Cardiodilatine, a new peptide hormone and production process thereof
05/26/1993CN1072415A Cyclic vasoactive peptides
05/26/1993CN1020857C Peptides corresponding to antigenic and immunogenic determinants of major nentralizing proteins of rotaviruses
05/25/1993US5214130 Synthesis of novel immunosuppressive cyclosporin analogs with modified amino acids at position-8
05/25/1993CA1318463C Polypeptide compounds having growth hormone releasing activity
05/19/1993EP0541726A1 Growth factor compositions, preparation and use
05/19/1993EP0541694A1 Method for treating immune system dysfunctions
05/19/1993EP0541686A1 Tachykinin agonists for treatment of alzheimer's disease
05/19/1993EP0541654A1 Bombesin antagonists
05/19/1993EP0541629A1 CLONING AND EXPRESSION OF A RHOPTRY ASSOCIATED PROTEIN OF $i(P.FALCIPARUM)
05/19/1993EP0343186B1 MOLECULES COMPRISING AT LEAST ONE PEPTIDIC SEQUENCE CARRYING ONE OR A PLURALITY OF EPITOPES CHARACTERIZING A PROTEIN PRODUCED BY $i(P. FALCIPARUM) IN HEPATOCYTES AND COMPOSITIONS CONTAINING THEM
05/18/1993US5212290 Monoclonal and polyclonal antibodies
05/18/1993US5212288 Temporary minimal protection synthesis of serine-containing polypeptides
05/18/1993US5212287 Pentapeptide synthesis
05/18/1993US5212072 Genetic engineering and DNA sequences
05/18/1993US5211657 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides
05/13/1993WO1993009135A1 Peptides inhibiting il-1 beta release
05/13/1993WO1993009134A1 Phosphonamidate ester-containing pseudopeptides
05/13/1993WO1993008826A1 Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs
05/13/1993WO1993008824A1 Synthetic lung surfactant having antioxidant properties
05/13/1993WO1993008817A1 Cd8 binding domain peptides
05/13/1993WO1993008816A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof
05/13/1993WO1993008815A1 Pharmaceutical dipeptide compositions and methods of use thereof
05/13/1993CA2122266A1 Cd8 binding domain peptides
05/13/1993CA2122024A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof
05/13/1993CA2116653A1 Peptides inhibiting il-1 beta release
05/12/1993EP0541058A1 Expression of a mature proteinase 2a, its partial purification and preparation of inhibitory active substrates
05/12/1993EP0540969A2 Derivatives of structurally modified VIP and pharmaceutical compositions containing them
05/12/1993EP0540709A1 Novel antipathogenic peptides and compositions containing same
05/12/1993EP0540675A1 Inhibition of mac-1 receptor binding to fibrinogen using d 30? homologs
05/12/1993EP0540626A1 Process for synthesizing peptides
05/12/1993EP0540586A1 Binding domains
05/12/1993CN1020616C Process for preparing de-(acetylglucosaminyl)-di (dehydro)-deoxyteicoplanin derivatives
05/11/1993US5210180 Nonapeptides
05/07/1993CA2082217A1 Expression of mature proteinase 2a, the partial purification thereof and preparation of substrates having an inhibitory effect
05/05/1993EP0540263A1 Bacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic form
05/05/1993EP0539530A1 Purification directed cloning of peptides
05/05/1993CA2081990A1 Antibodies specific for rar-gamma or a specific isoform of rar-gamma
04/1993
04/29/1993WO1993008290A1 Enhanced immunogenicity using leukotoxin chimeras
04/29/1993WO1993008288A1 Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form
04/29/1993WO1993000365A3 Hepatitis c virus (hcv) polypeptides
04/28/1993EP0539088A1 Echinocandin b derivative
04/28/1993EP0538942A2 Peptides representing permutations of the mastoparan sequence
04/28/1993EP0538399A1 Cyclic cell adhesion modulation compounds
04/28/1993EP0538398A1 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof
04/28/1993EP0538367A1 Derivatives of pituitary posterior lobe hormones
04/28/1993EP0499625A4 Conglutinin fragments, their production and use
04/28/1993CN1071333A Calcium receptor active molecules
04/27/1993US5206354 Dna sequence encoding active fragment of fibroblast growth factor, hbf-2
04/27/1993CA1317070C Inhibitor peptides i and ii
04/27/1993CA1317069C2 Synthetic peptides having pituitary growth hormone releasing activity
04/27/1993CA1317068C Peptides influencing diuresis and natriuresis, a process for their preparation, agents containing them, and their use
04/21/1993EP0538027A2 Cyclohexapeptides
04/21/1993EP0538002A1 Aminoalkyl thioether compounds
04/21/1993EP0537981A2 Cleavage method for acyl thiohydantoins and use of the method in C-terminal peptide sequencing
04/21/1993EP0537318A1 New non-hygroscopic mono-ammonium salts.
04/21/1993EP0537276A1 Cancer-associated scm-recognition factor, preparation and method of use
04/21/1993EP0343248B1 Novel polypeptide and method for preparing the same
04/20/1993US5204449 Carriers; drug delivery; veterinary medicine; target specificity; antifertility agents; animal growth regulators monoclonal antibodies; vaccines
04/18/1993CA2080759A1 Aminoalkylamides
04/18/1993CA2080757A1 Aminoalkyl thioether compounds
04/18/1993CA2080756A1 1-(4-hydroxy-5-aminoethyloxy-n2- (10,12-dimethyl-1-oxotetraecyl) ornithine)-5(3-hydroxyglutamine) -6-(3-hydroxyproline) echinocandin
04/17/1993WO1993008213A1 Novel physiologically active substance epimorphine, gene which codes for same, and antibody against epimorphine
04/15/1993WO1993007170A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa
04/15/1993WO1993007169A1 Peptide inhibitors of platelet adhesion
04/15/1993WO1993006843A1 Peptides corresponding to antigenic determinants of htlv
04/15/1993WO1993006841A1 A peptide analog
04/15/1993WO1993001210A3 Hcv peptide-antigens and a method of testing for the hepatitis c virus (hcv)
04/15/1993CA2120362A1 Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia
04/14/1993EP0536838A2 Non-A, non-B peptides
04/14/1993EP0536741A2 Cyclic VIP analogs
04/14/1993EP0536455A1 Novel microorganisms (Bacillus subtilis), antifungal peptides and processes for producing them
04/14/1993EP0536343A1 Targeted polymeric conjugates of cyclosporin and method for their preparation.
04/14/1993EP0536186A1 Bone and cartilage inductive proteins
04/14/1993EP0536177A1 Thrombin inhibitors based on the amino acid sequence of hirudin
04/14/1993EP0380546B1 Polypeptides with type iv collagen activity
04/14/1993EP0313651B1 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use
04/13/1993US5202310 Cyclosporine metabolites
04/13/1993US5202309 Antibiotic cyclopeptide fermentation product
04/11/1993CA2080309A1 Mutations in ryanodine receptor causative of human malignant hyperthermia
04/08/1993CA2079439A1 Non-a, non-b peptides
04/07/1993EP0535968A1 Cyclohexapeptidyl hydroxypropionitrile compounds
04/07/1993EP0535967A2 Cyclohexapeptidyl bisamine compounds
04/07/1993EP0535959A1 Cyclohexapeptidyl propanolamine compounds
04/07/1993EP0535804A1 Peptide compounds
04/07/1993EP0535155A1 Libraries of modified peptides with protease resistance
04/07/1993EP0535119A1 A novel vector to produce biologically important peptides
04/07/1993EP0535088A1 Chimeric toxins with improved inter-domain geometry